Advertisement
Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal
This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more
- Cytospire Therapeutics: £61m Series A Led by 4BIO Capital (2026-05-05)
> Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and LifeArc Ventures > Cytospire’s novel pan-gamma T cell engage... - Windward Bio: $165m Crossover Financing Led by OrbiMed (2026-05-04)
> Led by OrbiMed, with participation from RA Capital Management, Janus Henderson Investors, Sanofi Ventures, Harbour BioMed, and existing investors > Proceeds will advance lead candidate WIN378 into Phase 3 and WIN027 into respiratory and dermatology studies by ... - Leo Pharma to Acquire Gene Therapy Company Replay (2026-04-30)
> Acquisition adds high-payload herpes simplex virus (HSV) gene therapy targeting genetic skin diseases to LEO Pharma’s pipeline and further expands the company’s presence in rare dermatology > Combines LEO Pharma’s six decades of dermatology expertise wit... - CARB-X Awards Funding to AdJane to Advance Gonorrhea Vaccine (2026-04-28)
Heterologous approach aims to deliver targeted, broad-spectrum immune response to Neisseria gonorrhoeaeinfections Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$2.6 million to AdJane to advance the development of ... - Coultreon’s $125m Series A Is Led by Sofinnova Investments (2026-04-28)
> Financing led by Sofinnova Investments and co-led by Forbion and Novo Holdings > Proceeds to advance lead immunology program COL-5671, a potential first-in-class, oral once-daily therapy, across a range of auto-immune indications Coultreon Biopharma (form... - Ray Therapeutics’ $125m Series B Led by Janus Henderson (2026-04-21)
Funding provides significant capital to support late-stage clinical development and commercial readiness for lead program RTx-015 in Retinitis Pigmentosa, and clinical studies for RTx-021 in Stargardt Disease and Geographic Atrophy Ray Therapeutics (RayTx), an... - Proteins.1 Raises €4.7m in Pre-Seed Funding to Pioneer Omics (2026-04-16)
We’re excited to introduce Proteins.1, backed by Lifeline Ventures and Cloudberry with €4.7M in pre-seed funding, to pioneer omics. For decades, diagnostics has had a hard ceiling. While PCR revolutionized DNA analysis, there has never been a “PCR for prot... - Roche to Acquire Saga Diagnostics for up to $595m (2026-04-16)
> Pathlight™, a personalized, tumor-informed molecular residual disease (MRD) platform, will expand Foundation Medicine’s testing capabilities > Pathlight uses a proprietary combination of whole genome sequencing (WGS) and digital PCR to identify and track ... - Adcendo Closes $75m Series C Led by Jeito Capital (2026-04-14)
> Oversubscribed financing led by Jeito Capital, including additional new investment from Vida Ventures, BPI France, and EIFO, with participation from all existing investors > Proceeds to support the advancement of three first- and best-in-class ADC programs thr... - Novo Nordisk to Integrate OpenAI's AI Capabilities Globally (2026-04-14)
> Strategic partnership enables upskilling of Novo Nordisk’s workforce and places the company at the forefront of AI transformation in healthcare > Novo Nordisk will integrate OpenAI's most advanced AI capabilities globally from drug discovery to commercial op...
Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!
[LSS] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)




![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)


